{"id":"22fbdc2e-14ee-463c-afbd-7b95a0de8332","kind":"institutions","code":"UB-I4479","name":"Qianguangwangli","nameBasis":"transliterated","summary":"Qianguangwangli is a Chinese private equity firm, specializing in equity investment in growth-stage and mature unlisted companies.","description":"Qianguangwangli is a Chinese private equity firm, specializing in equity investment in growth-stage and mature unlisted companies.","country":null,"category":null,"originalName":"乾广旺利","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:46:27.175Z","englishUpdatedAt":"2026-10-15T18:43:03.537Z","reviewedAt":"2026-10-15T18:43:03.537Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1d577f4aaa1b80490b7e24008117fb469cda434255381ad46e2c2eb0467ed96f","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"作为中国私募股权机构，乾广旺利深耕成长期与成熟期未上市企业股权投资。","sources":[],"related":[{"id":"54a80428-68df-4153-b3e2-406e76e40b27","kind":"news","code":"54a80428-68df-4153-b3e2-406e76e40b27","name":"Keyin Biotechnology completes strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"科因生物完成战略投资融资","eventDate":"2022-12-20T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T22:00:24.014Z","englishUpdatedAt":"2026-10-16T01:39:38.719Z","reviewedAt":"2026-10-16T01:39:38.719Z","snapshotAt":"2026-10-16T01:38:14.029Z","sourceHash":"5d4bf76ff156d4c7589f534f07a27d461e0f5b51ee976b489921c2e8bdff387d","companyId":"938ed08f-eb36-40c6-99f0-d62f8456c3bd","foundedYear":null,"logoUrl":null,"path":"/news/54a80428-68df-4153-b3e2-406e76e40b27"}],"path":"/institutions/qianguangwangli","displayName":"乾广旺利","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"乾广旺利 is a private equity investor based in China (mainland) with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/qianguangwangli"}